Category: Disease States

Disease States

An AI-enhanced wastewater surveillance system has been developed to detect emerging viruses and variants earlier than traditional methods.

Researchers have identified over 250 proteins strongly affected by malaria, offering potential biomarkers to predict disease severity.

Diagnosing lupus remains a major challenge, but emerging biomarkers offer significant promise in improving early and accurate detection.

Vibrant Wellness has enhanced its Gut Zoomer microbiome panel with expanded microbial and metabolite testing.

Researchers have developed a handheld TB test that accurately detects tuberculosis in HIV-positive individuals using a single drop of blood.

Juniper Genomics has launched publicly to offer a next-generation embryo screening platform that aims to improve IVF outcomes.

rex Laboratories has launched BiomeBurden, a comprehensive test that evaluates immune responses to microbial, yeast, and mold triggers.

University of Tokyo researchers have developed a non-invasive, AI-powered imaging system that tracks platelet activity in real time.

Quanterix Corporation's HD-X Simoa Immunoassay Analyzer has received Class 1 Medical Device registration in South Korea.

Two studies demonstrate how AI models can significantly improve early detection of type 1 diabetes, enabling earlier intervention.

A pilot program using Healthy.io’s FDA-cleared smartphone-powered Minuteful Kidney test significantly improved CKD screening and diagnosis.

The Cystic Fibrosis Base assay has received IVDR accreditation, ensuring high standards for detecting cystic fibrosis mutations.

Researchers propose developing tiny chemical sensors that detect VOCs in bodily fluids to rapidly diagnose bacterial infections.